Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in previously untreated metastatic malignant melanoma
NCT00005971Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jul 2000
- Primary completion
- Aug 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of alvocidib in melanoma, sponsored by Canadian Cancer Trials Group. Primary endpoint: Objective Response Rate. Started Jul 2000; status: completed.
02
Drugs
alvocidib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00005971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005971.